0 XP   0   0   0

Ekso Bionics Holdings Inc










Financial Health of Ekso Bionics Holdings Inc




Comparing to competitors in the Medical Instruments & Supplies industry




  Industry Rankings  


Ekso Bionics Holdings Inc
Buy, Hold or Sell?

Should you buy, hold or sell Ekso Bionics Holdings Inc?

I guess you are interested in Ekso Bionics Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Ekso Bionics Holdings Inc

Let's start. I'm going to help you getting a better view of Ekso Bionics Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Ekso Bionics Holdings Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Ekso Bionics Holdings Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Ekso Bionics Holdings Inc. The closing price on 2022-12-02 was $1.22 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Ekso Bionics Holdings Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Ekso Bionics Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ekso Bionics Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -129.3% means that $-1.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -129.3%. The company is making a huge loss. -2
  • The TTM is -116.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-129.3%TTM-116.4%-12.9%
TTM-116.4%YOY-122.6%+6.2%
TTM-116.4%5Y-162.7%+46.3%
5Y-162.7%10Y-255.8%+93.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-129.3%7.5%-136.8%
TTM-116.4%7.3%-123.7%
YOY-122.6%8.7%-131.3%
5Y-162.7%6.8%-169.5%
10Y-255.8%7.0%-262.8%
1.1.2. Return on Assets

Shows how efficient Ekso Bionics Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • -10.9% Return on Assets means that Ekso Bionics Holdings Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ekso Bionics Holdings Inc:

  • The MRQ is -10.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-8.6%-2.3%
TTM-8.6%YOY-8.0%-0.6%
TTM-8.6%5Y-15.8%+7.2%
5Y-15.8%10Y-220.6%+204.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%1.5%-12.4%
TTM-8.6%1.4%-10.0%
YOY-8.0%1.5%-9.5%
5Y-15.8%1.2%-17.0%
10Y-220.6%1.3%-221.9%
1.1.3. Return on Equity

Shows how efficient Ekso Bionics Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • -15.0% Return on Equity means Ekso Bionics Holdings Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ekso Bionics Holdings Inc:

  • The MRQ is -15.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.0%TTM-11.5%-3.6%
TTM-11.5%YOY-26.7%+15.2%
TTM-11.5%5Y-44.3%+32.8%
5Y-44.3%10Y-55.0%+10.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.0%2.4%-17.4%
TTM-11.5%2.6%-14.1%
YOY-26.7%2.9%-29.6%
5Y-44.3%2.3%-46.6%
10Y-55.0%2.4%-57.4%

1.2. Operating Efficiency of Ekso Bionics Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ekso Bionics Holdings Inc is operating .

  • Measures how much profit Ekso Bionics Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -128.3% means the company generated $-1.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -128.3%. The company is operating very inefficient. -2
  • The TTM is -115.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-128.3%TTM-115.4%-12.9%
TTM-115.4%YOY-121.5%+6.0%
TTM-115.4%5Y-159.5%+44.1%
5Y-159.5%10Y-252.8%+93.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.3%10.1%-138.4%
TTM-115.4%9.8%-125.2%
YOY-121.5%10.8%-132.3%
5Y-159.5%7.9%-167.4%
10Y-252.8%7.2%-260.0%
1.2.2. Operating Ratio

Measures how efficient Ekso Bionics Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.10 means that the operating costs are $2.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 2.098. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.199. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.098TTM2.199-0.102
TTM2.199YOY2.351-0.151
TTM2.1995Y2.671-0.471
5Y2.67110Y3.032-0.361
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0981.172+0.926
TTM2.1991.094+1.105
YOY2.3510.990+1.361
5Y2.6711.046+1.625
10Y3.0321.006+2.026

1.3. Liquidity of Ekso Bionics Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 4.68 means the company has $4.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 4.677. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.758. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.677TTM6.758-2.081
TTM6.758YOY8.573-1.815
TTM6.7585Y4.545+2.213
5Y4.54510Y3.529+1.016
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6772.529+2.148
TTM6.7582.586+4.172
YOY8.5732.402+6.171
5Y4.5452.490+2.055
10Y3.5292.359+1.170
1.3.2. Quick Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 4.15 means the company can pay off $4.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 4.146. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.164. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.146TTM6.164-2.018
TTM6.164YOY8.073-1.909
TTM6.1645Y4.083+2.080
5Y4.08310Y3.079+1.004
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1461.102+3.044
TTM6.1641.064+5.100
YOY8.0731.119+6.954
5Y4.0831.094+2.989
10Y3.0791.026+2.053

1.4. Solvency of Ekso Bionics Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ekso Bionics Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ekso Bionics Holdings Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.27 means that Ekso Bionics Holdings Inc assets are financed with 27.2% credit (debt) and the remaining percentage (100% - 27.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 0.272. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.244. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.272TTM0.244+0.028
TTM0.244YOY0.383-0.139
TTM0.2445Y0.551-0.307
5Y0.55110Y6.338-5.787
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2720.347-0.075
TTM0.2440.341-0.097
YOY0.3830.368+0.015
5Y0.5510.376+0.175
10Y6.3380.372+5.966
1.4.2. Debt to Equity Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 37.4% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 0.374. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.323. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.374TTM0.323+0.051
TTM0.323YOY1.161-0.838
TTM0.3235Y1.704-1.381
5Y1.70410Y1.735-0.031
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3740.517-0.143
TTM0.3230.520-0.197
YOY1.1610.591+0.570
5Y1.7040.628+1.076
10Y1.7350.632+1.103

2. Market Valuation of Ekso Bionics Holdings Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ekso Bionics Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -4.74 means the investor is paying $-4.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is -3.705. Company is losing money. -2
  • The MRQ is -4.738. Company is losing money. -2
  • The TTM is -8.040. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.705MRQ-4.738+1.033
MRQ-4.738TTM-8.040+3.303
TTM-8.040YOY-32.251+24.210
TTM-8.0405Y-7.578-0.463
5Y-7.57810Y-4.758-2.819
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-3.70559.546-63.251
MRQ-4.73861.746-66.484
TTM-8.04085.285-93.325
YOY-32.25198.197-130.448
5Y-7.57857.263-64.841
10Y-4.75853.213-57.971
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Ekso Bionics Holdings Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 15.496. Seems overpriced? -1
  • The TTM is 15.494. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ15.496TTM15.494+0.002
TTM15.494YOY-48.067+63.562
TTM15.4945Y-1.547+17.042
5Y-1.54710Y0.327-1.874
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ15.496-0.016+15.512
TTM15.494-0.191+15.685
YOY-48.0670.014-48.081
5Y-1.5470.044-1.591
10Y0.3270.101+0.226

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ekso Bionics Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is 0.557. Very good. +2
  • The MRQ is 0.713. Very good. +2
  • The TTM is 0.860. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.557MRQ0.713-0.155
MRQ0.713TTM0.860-0.148
TTM0.860YOY5.825-4.964
TTM0.8605Y-191.880+192.741
5Y-191.88010Y-95.077-96.803
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.5572.751-2.194
MRQ0.7132.850-2.137
TTM0.8603.702-2.842
YOY5.8254.453+1.372
5Y-191.8803.597-195.477
10Y-95.0773.186-98.263
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ekso Bionics Holdings Inc.

3.1. Institutions holding Ekso Bionics Holdings Inc

Institutions are holding 15.96% of the shares of Ekso Bionics Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Vanguard Group Inc3.3829044068300
2022-06-30Essex Investment Management Company, LLC1.28690.044816764500
2022-06-30Sabby Management LLC1.09130.1599142165-256635-64.3518
2022-06-30Geode Capital Management, LLC0.83010812200
2022-06-30Renaissance Technologies Corp0.34240.00014460627006153.4432
2022-06-30Susquehanna International Group, LLP0.227302961018336162.6397
2022-06-30Compagnie Lombard, Odier SCA0.19190.0012500000
2022-06-30Citadel Advisors Llc0.1913024920249200
2022-06-30State Street Corporation0.177902318015006.9188
2022-09-30Strategic Wealth Designers0.17210.010122419-7982-26.2557
2022-06-30Northern Trust Corp0.1567020414-3184-13.4927
2022-06-30TWO SIGMA SECURITIES, LLC0.15130.001219707197070
2022-06-30Virtu Financial LLC0.08680.001611306113060
2022-06-30JANE STREET GROUP, LLC0.0865011262112620
2022-06-30Advisor Group Holdings, Inc.0.0760989500
2022-09-30Hanson Mcclain Inc0.04630.0001602900
2022-06-30UBS Group AG0.04620602460240
2022-06-30Tower Research Capital LLC0.02710.0001352435240
2022-06-30SIMPLEX TRADING, LLC0.0257033532777482.1181
2022-06-30Group One Trading, LP0.014301869-1919-50.66
Total 8.61090.21891121733-143358-12.8%

3.2. Funds holding Ekso Bionics Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30AZ Fd1 AZ Allc Tr A-AZ C4.6060.050160000000
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr1.868402433851000.0411
2022-10-31Vanguard Total Stock Mkt Idx Inv1.8684024338500
2022-10-31Vanguard Extended Market Index Investor1.37540.000417916500
2022-09-30Fidelity® Extended Market Index0.53870.00047016800
2022-09-30Azimut Trend0.26870.0383500000
2022-10-31iShares Core S&P Total US Stock Mkt ETF0.13380.00011743000
2022-06-30Essex Inv Mgt Micro Cap Growth0.12090.39161575100
2022-09-30Fidelity® Total Market Index0.113901483800
2022-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.10810.00011408500
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.09310.00041213300
2022-09-30Fidelity® Series Total Market Index0.090401178000
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.07510.000497841311.3571
2022-09-30AZ Fd 1 Equity Escalator B-AZ EUR Dis0.05380.00137005-36-0.5113
2022-09-30NT Ext Equity Mkt Idx Fd - L0.05340.0003696200
2022-09-30Northern Trust Extended Eq Market Idx0.05340.0003696200
2022-06-30BlackRock Extended Mkt Composite0.05290.0001689268920
2022-06-30Trecento Robotique ISR I EUR0.05130.277166812574.0006
2022-09-30BlackRock Extended Equity Market K0.04670.00016085-56-0.9119
2022-09-30Fidelity® NASDAQ Composite Index®0.04490.0001584300
Total 11.61730.76081513334+7288+0.5%

3.3. Insider Transactions

Insiders are holding 8.024% of the shares of Ekso Bionics Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-10-24Steven ShermanSELL59211.29698230
2022-09-22Steven ShermanSELL60431.75688551
2022-08-22Steven ShermanSELL55722.2678995
2022-08-03Jerome WongSELL16751.8102192
2022-07-25Steven ShermanSELL56621.75668968
2022-07-18Jerome WongSELL981.71103867
2022-06-30Scott G DavisSELL49971.72368818
2022-06-22Steven ShermanSELL53301.74659031
2022-06-15Steven ShermanSELL69111.9648762
2022-05-24Steven ShermanSELL65971.76637408
2022-04-28Steven ShermanSELL68622.41628406
2022-04-20Scott G DavisSELL40432.6273815
2022-03-24Steven ShermanSELL63892.94
2022-03-22Jason C JonesSELL32652.82
2022-03-22John GlennSELL34622.82
2022-03-15Steven ShermanSELL59652.6
2018-05-23Steven ShermanBUY2000001.51
2017-11-22Russ AngoldSELL500003.51
2017-09-14Amy Mcbride WendellBUY162641.2316264
2017-09-08Thomas LoobyBUY150001.1320315

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ekso Bionics Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.247-0.202-18%0.588-142%-0.004-98%0.055-550%
Book Value Growth---0.109-0.081-25%-0.013-88%-9.490+8617%-4.817+4325%
Book Value Per Share--2.1892.513-13%2.391-8%1.322+66%0.715+206%
Book Value Per Share Growth---0.113-0.082-27%-0.013-89%-9.490+8325%-4.817+4177%
Current Ratio--4.6776.758-31%8.573-45%4.545+3%3.529+33%
Debt To Asset Ratio--0.2720.244+12%0.383-29%0.551-51%6.338-96%
Debt To Equity Ratio--0.3740.323+16%1.161-68%1.704-78%1.735-78%
Dividend Per Share----0%-0%-0%-0%
Eps---0.329-0.283-14%-0.209-37%-0.158-52%-0.426+29%
Eps Growth---0.306-0.113-63%0.000-100%0.837-137%0.781-139%
Gross Profit Margin--1.4051.522-8%1.800-22%0.850+65%1.059+33%
Net Profit Margin---1.293-1.164-10%-1.226-5%-1.627+26%-2.558+98%
Operating Margin---1.283-1.154-10%-1.215-5%-1.595+24%-2.528+97%
Operating Ratio--2.0982.199-5%2.351-11%2.671-21%3.032-31%
Pb Ratio0.557-28%0.7130.860-17%5.825-88%-191.880+27026%-95.077+13442%
Pe Ratio-3.705+22%-4.738-8.040+70%-32.251+581%-7.578+60%-4.758+0%
Peg Ratio--15.49615.494+0%-48.067+410%-1.547+110%0.327+4639%
Price Per Share1.220-28%1.5602.188-29%5.605-72%3.047-49%2.347-34%
Price To Total Gains Ratio-4.948+22%-6.326-11.844+87%-39.411+523%-10.743+70%-8.233+30%
Profit Growth---30.809-11.328-63%-0.005-100%104.373-130%53.341-158%
Quick Ratio--4.1466.164-33%8.073-49%4.083+2%3.079+35%
Return On Assets---0.109-0.086-21%-0.080-27%-0.158+45%-2.206+1915%
Return On Equity---0.150-0.115-24%-0.267+78%-0.443+195%-0.550+266%
Revenue Growth---0.041-0.029-28%-0.014-67%-0.022-46%-0.071+74%
Total Gains Per Share---0.247-0.202-18%0.588-142%-0.004-98%0.055-550%
Total Gains Per Share Growth---0.453-0.068-85%-11.184+2369%-2.367+423%-1.275+181%
Usd Book Value--28614000.00032762000.000-13%31141750.000-8%17227150.000+66%9321591.300+207%
Usd Book Value Change Per Share---0.247-0.202-18%0.588-142%-0.004-98%0.055-550%
Usd Book Value Per Share--2.1892.513-13%2.391-8%1.322+66%0.715+206%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.329-0.283-14%-0.209-37%-0.158-52%-0.426+29%
Usd Price Per Share1.220-28%1.5602.188-29%5.605-72%3.047-49%2.347-34%
Usd Profit---4304000.000-3691250.000-14%-2719250.000-37%-4279750.000-1%-4564652.025+6%
Usd Revenue--3329000.0003359250.000-1%2356000.000+41%2859550.000+16%2340050.000+42%
Usd Total Gains Per Share---0.247-0.202-18%0.588-142%-0.004-98%0.055-550%
 EOD+3 -2MRQTTM+4 -29YOY+9 -245Y+19 -1410Y+23 -10

4.2. Fundamental Score

Let's check the fundamental score of Ekso Bionics Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.705
Price to Book Ratio (EOD)Between0-10.557
Net Profit Margin (MRQ)Greater than0-1.293
Operating Margin (MRQ)Greater than0-1.283
Quick Ratio (MRQ)Greater than14.146
Current Ratio (MRQ)Greater than14.677
Debt to Asset Ratio (MRQ)Less than10.272
Debt to Equity Ratio (MRQ)Less than10.374
Return on Equity (MRQ)Greater than0.15-0.150
Return on Assets (MRQ)Greater than0.05-0.109
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Ekso Bionics Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.240
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets39,311
Total Liabilities10,697
Total Stockholder Equity28,614
 As reported
Total Liabilities 10,697
Total Stockholder Equity+ 28,614
Total Assets = 39,311

Assets

Total Assets39,311
Total Current Assets36,754
Long-term Assets36,754
Total Current Assets
Cash And Cash Equivalents 29,180
Net Receivables 3,398
Inventory 3,508
Other Current Assets 668
Total Current Assets  (as reported)36,754
Total Current Assets  (calculated)36,754
+/-0
Long-term Assets
Property Plant Equipment 2,333
Other Assets 224
Long-term Assets  (as reported)2,557
Long-term Assets  (calculated)2,557
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,858
Long-term Liabilities2,839
Total Stockholder Equity28,614
Total Current Liabilities
Short-term Debt 244
Short Long Term Debt 1,996
Accounts payable 2,387
Other Current Liabilities 4,168
Total Current Liabilities  (as reported)7,858
Total Current Liabilities  (calculated)8,795
+/- 937
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,167
Other Liabilities 1,672
Long-term Liabilities  (as reported)2,839
Long-term Liabilities  (calculated)2,839
+/-0
Total Stockholder Equity
Common Stock13
Retained Earnings -220,769
Accumulated Other Comprehensive Income 1,486
Other Stockholders Equity 247,884
Total Stockholder Equity (as reported)28,614
Total Stockholder Equity (calculated)28,614
+/-0
Other
Capital Stock13
Cash and Short Term Investments 29,180
Common Stock Shares Outstanding 13,071
Current Deferred Revenue1,059
Liabilities and Stockholders Equity 39,311
Net Debt -27,769
Net Invested Capital 30,610
Net Tangible Assets 28,614
Net Working Capital 28,896
Short Long Term Debt Total 1,411



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-30
> Total Assets 
5
13
30
29
29
0
0
21,801
18,598
15,418
33,474
30,033
26,906
22,126
32,198
22,551
13,575
21,621
24,425
16,895
18,932
43,405
37,988
30,959
23,208
22,423
17,655
20,860
25,583
20,292
21,915
16,944
22,349
23,486
20,597
56,504
52,973
50,733
49,166
44,242
40,520
39,311
39,31140,52044,24249,16650,73352,97356,50420,59723,48622,34916,94421,91520,29225,58320,86017,65522,42323,20830,95937,98843,40518,93216,89524,42521,62113,57522,55132,19822,12626,90630,03333,47415,41818,59821,80100292930135
   > Total Current Assets 
5
13
30
29
29
0
0
18,856
15,306
11,662
29,300
25,550
22,182
17,248
25,201
18,221
9,367
17,574
20,684
13,262
15,301
40,168
34,937
27,937
20,403
19,853
14,967
16,835
22,133
17,034
18,807
14,062
19,910
21,549
18,420
54,605
51,295
49,099
47,795
43,123
39,323
36,754
36,75439,32343,12347,79549,09951,29554,60518,42021,54919,91014,06218,80717,03422,13316,83514,96719,85320,40327,93734,93740,16815,30113,26220,68417,5749,36718,22125,20117,24822,18225,55029,30011,66215,30618,85600292930135
       Cash And Cash Equivalents 
5
13
30
29
29
0
0
14,576
10,965
7,176
25,190
21,133
16,251
11,238
19,552
12,314
4,661
12,800
16,846
9,426
10,701
33,439
27,813
20,572
13,890
12,995
7,655
9,236
13,262
8,058
10,872
8,516
13,260
14,549
12,862
49,539
45,938
43,439
40,406
36,176
31,912
29,180
29,18031,91236,17640,40643,43945,93849,53912,86214,54913,2608,51610,8728,05813,2629,2367,65512,99513,89020,57227,81333,43910,7019,42616,84612,8004,66112,31419,55211,23816,25121,13325,1907,17610,96514,57600292930135
       Net Receivables 
0
0
0
0
0
0
0
1,775
1,494
1,922
1,549
1,455
2,394
2,185
2,069
2,383
1,606
2,234
1,780
1,282
2,107
2,168
2,760
3,574
3,547
2,988
3,660
3,793
4,541
5,206
5,208
2,658
3,741
4,450
3,389
2,276
2,756
3,121
4,662
3,346
3,341
3,398
3,3983,3413,3464,6623,1212,7562,2763,3894,4503,7412,6585,2085,2064,5413,7933,6602,9883,5473,5742,7602,1682,1071,2821,7802,2341,6062,3832,0692,1852,3941,4551,5491,9221,4941,7750000000
       Other Current Assets 
0
0
0
0
0
0
0
1,381
1,570
1,700
1,939
2,124
2,349
2,646
2,524
993
692
625
502
735
597
2,183
1,339
958
584
509
281
506
606
428
238
405
525
370
191
636
648
788
485
829
796
668
6687968294857886486361913705254052384286065062815095849581,3392,1835977355026256929932,5242,6462,3492,1241,9391,7001,5701,3810000000
   > Long-term Assets 
0
0
0
0
0
0
0
2,945
3,292
3,756
4,174
4,483
4,724
4,878
6,997
4,330
4,208
4,047
3,741
3,633
3,631
3,237
3,051
3,022
2,805
2,570
2,688
4,025
3,450
3,258
3,108
2,882
2,439
1,937
2,177
1,899
1,678
1,634
1,371
1,119
1,197
2,557
2,5571,1971,1191,3711,6341,6781,8992,1771,9372,4392,8823,1083,2583,4504,0252,6882,5702,8053,0223,0513,2373,6313,6333,7414,0474,2084,3306,9974,8784,7244,4834,1743,7563,2922,9450000000
       Property Plant Equipment 
0
0
0
0
0
0
0
1,764
1,840
1,957
2,102
2,183
2,154
2,399
2,625
2,617
2,579
2,561
2,435
2,458
2,562
2,301
2,249
2,350
2,271
2,170
2,365
3,696
3,093
2,897
2,741
2,511
2,133
1,819
1,857
1,664
1,515
1,509
1,207
978
1,069
2,333
2,3331,0699781,2071,5091,5151,6641,8571,8192,1332,5112,7412,8973,0933,6962,3652,1702,2712,3502,2492,3012,5622,4582,4352,5612,5792,6172,6252,3992,1542,1832,1021,9571,8401,7640000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
0
0
0
0
0
0
0
0
0
00000000018918918918918918918918918918918918918918918918918918918900000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
55
0
0
0
1,584
1,431
1,297
1,162
1,026
894
762
626
491
359
225
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000902253594916267628941,0261,1621,2971,4311,584000550000000000
       Other Assets 
0
0
0
0
0
0
0
1,181
1,451
1,799
2,072
2,300
2,570
2,479
4,372
1,713
1,629
1,486
1,306
1,175
1,069
936
802
124
120
121
134
140
168
172
178
182
117
118
1,005
235
163
125
164
141
128
224
2241281411641251632351,0051181171821781721681401341211201248029361,0691,1751,3061,4861,6291,7134,3722,4792,5702,3002,0721,7991,4511,1810000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000002,50200000000000000
> Total Liabilities 
10
19
19
14
14
10
16
96,337
36,706
21,340
10,674
10,936
12,971
12,880
23,390
15,798
12,014
13,393
17,894
18,278
17,304
13,738
16,597
16,120
15,582
16,836
14,927
16,326
20,179
13,871
15,118
11,716
22,377
15,085
16,163
15,529
12,877
11,671
11,947
10,756
8,791
10,697
10,6978,79110,75611,94711,67112,87715,52916,16315,08522,37711,71615,11813,87120,17916,32614,92716,83615,58216,12016,59713,73817,30418,27817,89413,39312,01415,79823,39012,88012,97110,93610,67421,34036,70696,33716101414191910
   > Total Current Liabilities 
10
19
19
14
14
10
16
5,613
6,105
5,896
6,614
6,708
8,357
8,256
8,619
7,849
5,792
5,506
6,314
7,021
6,587
6,592
9,165
10,028
9,395
10,185
10,132
9,710
9,343
8,087
7,832
7,550
7,129
5,233
4,974
5,981
4,681
4,675
6,855
5,970
4,819
7,858
7,8584,8195,9706,8554,6754,6815,9814,9745,2337,1297,5507,8328,0879,3439,71010,13210,1859,39510,0289,1656,5926,5877,0216,3145,5065,7927,8498,6198,2568,3576,7086,6145,8966,1055,61316101414191910
       Short-term Debt 
0
0
18
9
9
9
11
39
40
41
41
42
43
79
80
81
78
67
54
432
972
1,556
2,173
2,367
2,368
2,368
2,368
2,775
2,762
2,768
2,772
2,604
2,702
406
548
1,361
514
372
229
97
51
244
24451972293725141,3615484062,7022,6042,7722,7682,7622,7752,3682,3682,3682,3672,1731,556972432546778818079434241414039119991800
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
41
0
0
0
80
0
0
0
6,843
432
972
1,556
2,139
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,170
2,433
0
0
814
0
0
0
0
0
1,996
1,99600000814002,4332,1702,3332,3332,3332,3332,3332,3332,3332,3332,1391,5569724326,84300080000410000000000
       Accounts payable 
0
0
0
0
0
0
4
1,044
1,227
1,077
783
1,464
2,306
2,148
2,694
3,618
2,074
1,359
1,879
2,867
2,068
990
2,420
3,392
2,590
3,438
3,156
2,474
2,480
1,362
1,903
1,999
1,902
1,813
1,501
1,652
1,428
1,308
3,107
2,939
2,045
2,387
2,3872,0452,9393,1071,3081,4281,6521,5011,8131,9021,9991,9031,3622,4802,4743,1563,4382,5903,3922,4209902,0682,8671,8791,3592,0743,6182,6942,1482,3061,4647831,0771,2271,0444000000
       Other Current Liabilities 
10
19
1
0
5
1
1
1,570
1,267
1,323
2,378
1,657
1,976
2,190
1,885
2,928
2,930
2,982
3,556
2,747
2,599
2,804
3,469
2,977
3,127
3,434
3,506
3,250
2,732
2,559
1,665
1,716
1,180
1,566
1,429
1,475
1,317
1,704
2,299
1,819
1,583
4,168
4,1681,5831,8192,2991,7041,3171,4751,4291,5661,1801,7161,6652,5592,7323,2503,5063,4343,1272,9773,4692,8042,5992,7473,5562,9822,9302,9281,8852,1901,9761,6572,3781,3231,2671,570115011910
   > Long-term Liabilities 
0
0
0
0
0
0
0
90,724
30,601
15,444
4,060
4,228
4,614
4,624
14,771
7,949
6,222
7,887
11,580
11,257
10,717
7,146
7,432
6,092
6,187
6,651
4,795
6,616
10,836
5,784
7,286
4,166
15,248
9,852
11,189
9,548
8,196
6,996
5,092
4,786
3,972
2,839
2,8393,9724,7865,0926,9968,1969,54811,1899,85215,2484,1667,2865,78410,8366,6164,7956,6516,1876,0927,4327,14610,71711,25711,5807,8876,2227,94914,7714,6244,6144,2284,06015,44430,60190,7240000000
       Long term Debt Total 
0
0
0
0
0
0
0
88,162
0
11,908
77
0
0
225
9,195
6,210
4,545
6,165
10,335
0
0
0
0
0
4,874
3,199
2,648
2,105
1,538
972
407
1,788
13,005
7,639
9,112
7,763
6,617
0
0
0
0
0
000006,6177,7639,1127,63913,0051,7884079721,5382,1052,6483,1994,8740000010,3356,1654,5456,2109,195225007711,908088,1620000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000002,50200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
90,613
30,502
15,356
3,983
4,163
4,561
4,624
14,625
7,824
6,114
7,788
4,701
4,730
4,738
1,713
2,546
1,755
2,406
3,425
2,147
3,505
8,364
3,994
6,168
3,571
14,096
6,400
7,881
7,187
6,205
5,004
3,099
2,792
1,863
1,672
1,6721,8632,7923,0995,0046,2057,1877,8816,40014,0963,5716,1683,9948,3643,5052,1473,4252,4061,7552,5461,7134,7384,7304,7017,7886,1147,82414,6254,6244,5614,1633,98315,35630,50290,6130000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
2,562
0
3,536
3,983
0
0
4,399
4,613
766
747
822
805
776
653
685
816
766
1,201
1,535
0
36
36
36
36
66
0
0
0
0
0
0
0
0
0
0
0000000000663636363601,5351,2017668166856537768058227477664,6134,399003,9833,53602,5620000000
> Total Stockholder Equity
-5
-6
11
0
15
-10
-16
-74,536
-18,109
-5,922
22,800
19,097
13,935
9,246
8,808
6,753
1,561
8,228
6,531
-1,383
1,628
29,667
21,391
14,839
7,626
5,587
2,728
4,534
5,404
6,421
6,797
5,228
-28
8,401
4,434
40,975
40,096
39,062
37,219
33,486
31,729
28,614
28,61431,72933,48637,21939,06240,09640,9754,4348,401-285,2286,7976,4215,4044,5342,7285,5877,62614,83921,39129,6671,628-1,3836,5318,2281,5616,7538,8089,24613,93519,09722,800-5,922-18,109-74,536-16-1015011-6-5
   Common Stock
5
5
6
0
6
6
6
78
79
79
102
102
102
102
105
109
16
21
22
22
26
60
60
60
61
63
63
68
75
75
87
6
8
8
8
13
13
13
13
13
13
13
1313131313131388868775756863636160606026222221161091051021021021027979786660655
   Retained Earnings -220,769-216,465-213,487-208,867-206,004-204,046-202,773-199,103-195,127-197,579-185,812-183,278-180,557-180,763-177,697-171,146-167,014-160,031-152,055-144,154-135,176-128,841-123,334-114,861-109,284-100,806-95,042-91,391-86,746-81,561-75,916-71,801-51,646-63,670-119,797-48-42-17-17-13-11-10
   Capital Surplus 
0
0
0
0
0
0
26
45,183
0
45,645
94,499
0
0
95,890
100,094
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
0
0
0
0
0
00000244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686100,09495,8900094,49945,645045,18326000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
18
0
26
26
26
45,183
45,483
45,645
96,001
94,911
95,394
95,890
102,347
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
245,299
246,090
246,765
247,347
247,884
247,884247,347246,765246,090245,299244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686102,34795,89095,39494,91196,00145,64545,48345,18326262601800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue11,246
Cost of Revenue-4,497
Gross Profit6,7496,749
 
Operating Income (+$)
Gross Profit6,749
Operating Expense-20,577
Operating Income-13,828-13,828
 
Operating Expense (+$)
Research Development2,748
Selling General Administrative10,524
Selling And Marketing Expenses7,305
Operating Expense20,57720,577
 
Net Interest Income (+$)
Interest Income-
Interest Expense-113
Net Interest Income-113-113
 
Pretax Income (+$)
Operating Income-13,828
Net Interest Income-113
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-9,764-17,892
EBIT - interestExpense = -9,764
-9,764
-9,651
Interest Expense113
Earnings Before Interest and Taxes (ebit)-9,651-9,651
Earnings Before Interest and Taxes (ebitda)-9,090
 
After tax Income (+$)
Income Before Tax-9,764
Tax Provision--
Net Income From Continuing Ops-9,764-9,764
Net Income-9,764
Net Income Applicable To Common Shares-9,764
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses25,074
Total Other Income/Expenses Net4,064113
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SPTE.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPTE.LSE.

SPTE.LSE Daily Candlestick Chart
SHP1.LSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SHP1.LSE.

SHP1.LSE Daily Candlestick Chart
PLTS.LSE
1 minute ago

I found you a Death Cross on the daily chart of PLTS.LSE.

PLTS.LSE Daily Candlestick Chart
PDD.LSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PDD.LSE.

PDD.LSE Daily Candlestick Chart
NRJL.LSE
2 minutes ago

I found you a Death Cross on the daily chart of NRJL.LSE.

NRJL.LSE Daily Candlestick Chart
IEEU.LSE
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IEEU.LSE.

IEEU.LSE Daily Candlestick Chart
EUSR.LSE
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EUSR.LSE.

EUSR.LSE Daily Candlestick Chart
APEX.LSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of APEX.LSE.

APEX.LSE Daily Candlestick Chart
3SRR.LSE
4 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of 3SRR.LSE.

3SRR.LSE Daily Candlestick Chart
3SHE.LSE
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3SHE.LSE.

3SHE.LSE Daily Candlestick Chart
CO2P.LSE
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CO2P.LSE.

CO2P.LSE Daily Candlestick Chart
K3C.LSE
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of K3C.LSE.

K3C.LSE Daily Candlestick Chart
PBEE.LSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PBEE.LSE.

PBEE.LSE Daily Candlestick Chart
BIOM.LSE
13 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of BIOM.LSE.

BIOM.LSE Daily Candlestick Chart
IGAS.LSE
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IGAS.LSE.

IGAS.LSE Daily Candlestick Chart
FOUR.LSE
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FOUR.LSE.

FOUR.LSE Daily Candlestick Chart
GOODYEAR.NSE
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GOODYEAR.NSE.

GOODYEAR.NSE Daily Candlestick Chart
LQDH.LSE
18 minutes ago

I found you a Golden Cross on the daily chart of LQDH.LSE.

LQDH.LSE Daily Candlestick Chart
LSIL.LSE
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LSIL.LSE.

LSIL.LSE Daily Candlestick Chart
W7L.LSE
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of W7L.LSE.

W7L.LSE Daily Candlestick Chart
SCF.LSE
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCF.LSE.

SCF.LSE Daily Candlestick Chart
KHANDSE.BSE
31 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KHANDSE.BSE.

KHANDSE.BSE Daily Candlestick Chart
BHARATSE.BSE
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BHARATSE.BSE.

BHARATSE.BSE Daily Candlestick Chart
BEMHY.BSE
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BEMHY.BSE.

BEMHY.BSE Daily Candlestick Chart